Evidence map›Paper›PMID 39684340›Full record

ArticleInternational journal of molecular sciences2024

The Synergic Immunomodulatory Effect of Vitamin D and Chickpea Protein Hydrolysate in THP-1 Cells: An In Vitro Approach.

Ángela Alcalá-Santiago, Rocío Toscano-Sánchez, José Carlos Márquez-López, José Antonio González-Jurado, María-Soledad Fernández-Pachón, Belén García-Villanova, Justo Pedroche, Noelia María Rodríguez-Martín

Registry-linked trialAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07765719 (Evaluation of New Disruptive Technologies), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07765719 nacompletednot on this map

Evaluation of New Disruptive Technologies (Steam Explosion) in the Design of Tailor-made Plant Protein Hydrolysates Applied to Sport Nutrition (PROVERDE)

TypeinterventionalSponsorInstituto de la GrasaRan2022 to 2022Enrolled51ConditionsPost-Exercise RecoveryArmsChickpea Protein Hydrolysate Beverage, Maltodextrin Placebo Beverage
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ángela Alcalá-SantiagoDepartment of Nutrition and Food Science, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0003-0648-5339
Rocío Toscano-SánchezDepartment of Medical Biochemistry, Molecular Biology, and Immunology, Faculty of Medicine, University of Seville, Av. Dr. Fedriani 3, 41071 Seville, Spain.
José Carlos Márquez-LópezGroup of Plant Proteins, Instituto de la Grasa-CSIC, 41013 Seville, Spain.
José Antonio González-JuradoPhysical and Sport Education, Physical Performance and Sports Research Center, University Pablo de Olavide, 41013 Sevilla, Spain.ORCID 0000-0003-2222-6089
María-Soledad Fernández-PachónArea of Nutrition and Food Sciences, Department of Molecular Biology, and Biochemistry Engineering, University Pablo de Olavide, 41013 Seville, Spain.ORCID 0000-0002-9524-298X
Belén García-VillanovaDepartment of Nutrition and Food Science, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-5114-300X
Justo PedrocheGroup of Plant Proteins, Instituto de la Grasa-CSIC, 41013 Seville, Spain.
Noelia María Rodríguez-MartínGroup of Plant Proteins, Instituto de la Grasa-CSIC, 41013 Seville, Spain.ORCID 0000-0003-4737-2330

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D (VD), a crucial micronutrient, regulates bone health and immune responses. Recent studies suggest that VD may confer protective effects against chronic inflammatory diseases. Additionally, plant-based peptides can show biological activities. Furthermore, the supplementation of protein hydrolysates with VD could potentially enhance the bioactivity of peptides, leading to synergistic effects. In this study, THP-1 cells were exposed to low concentrations of Lipopolysaccharide (LPS) to induce inflammation, followed by treatment with vitamin D at different concentrations (10, 25, or 50 nM) or a chickpea protein hydrolysate ("H30BIO") supplemented with VD. The cytotoxicity of VD was evaluated using viability assay to confirm its safety. The cytokine secretion of TNF-α, IL-1β, and IL6 was assessed in the cell supernatant, and the gene expression of

Indexed as

CicerCytokinesProtein HydrolysatesVitamin DCell SurvivalDrug SynergismHumansImmunologic FactorsInflammationLipopolysaccharidesNF-kappa BTHP-1 CellsCytokinesImmunologic FactorsLipopolysaccharidesNF-kappa BProtein HydrolysatesVitamin Danti-inflammatorybioactive compoundsNF-κBprotein hydrolysatesynergistic interactionvitamin D

Identifiers

PMID39684340
PMCPMC11640949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.